Hematology 2025_ Event Postponement
This is to inform that due to some circumstances beyond the organizer control, "2nd Edition of International Summit on Hematology and Blood Disorders" (Hematology 2025) June 05-07, 2025 | Hybrid Event has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at hematology@magnusconference.com or call + 1 (702) 988 2320.
2nd Edition of International Summit on Hematology and Blood Disorders
June 05-07, 2025
Transplantation Biology and New Therapeutic Avenues
A bone marrow transplant is a treatment that replaces the damaged or diseased bone marrow with healthy blood-forming stem cells. A stem cell transplant is another name for a bone marrow transplant. For patients with hematologic malignancies, hematopoietic cell transplantation (HCT) is a life-prolonging or potentially curative therapy option. These therapeutic techniques were initially limited to younger patients due to the significant transplant-related morbidity, but they are increasingly being employed in older adults. The incidence of most hematologic malignancies rises with age, and as the population ages, so does the number of prospective older HCT candidates. Allogeneic haemopoietic stem cell transplantation (HSCT) is used to treat a limited number of individuals with a variety of malignant and non-malignant blood illnesses, as well as other immune system problems.
Jie Xu
The University of Texas MD Anderson Cancer Center, United States
Ravishankar Rao Baikady
The Royal Marsden NHS Foundation Trust, United Kingdom
Peter J Van Der Spek
Erasmus University Medical Center, Netherlands
Aida I Richardson
Ann & Robert H. Lurie Children's Hospital of Chicago, United States
Maryam Asif
University of Washington, United States
Raykina Elena
Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology, Russian Federation
Santosh Kumar Mondal
Department of Pathology and Laboratory Medicine AIIMS, IndiaSubmit your abstract Today
Title : Single cell multi-omics in PBMC’s
Peter J Van Der Spek, Erasmus University Medical Center, Netherlands
Title : Myeloid neoplasms and molecular genetic alterations (Germline vs Somatic) that characterize specific entities in pediatric patients
Aida I Richardson, Ann & Robert H. Lurie Children's Hospital of Chicago, United States
Title : Overview of 2021 guidelines on the diagnosis of Von Willebrand Disease (VWD)
Maryam Asif, University of Washington, United States
Title : Clinical management of sickle cell disease
Lambros K Bourantas, Larnaca General Hospital, Cyprus
Title : Clonal evolution in children with inherited bone marrow failure syndromes
Raykina Elena, Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology, Russian Federation
Title : Blood transfusion challenges for one stop perioperative clinic care
Hanadi M Aljedani, King Abdullah Medical City, Saudi Arabia